Canadian Pharmaceuticals & Biotech Most Popular Stocks

C21 Investments

Market Cap: CA$43.3m

An integrated cannabis company, cultivates, processes, distributes, and sells cannabis and hemp-derived consumer products in the United States.

Sona Nanotech

Market Cap: CA$43.0m

Operates as a nanotechnology life sciences company in the United States and Canada The company researchers and develops gold nanoparticles for potential therapies, including photothermal therapy, tumor targeting activity, anti-bacterial activity, and drug delivery vehicle, as well as diagnostics, such as diagnostic markers for imaging and immunoassay and biosensing.

Sernova Biotherapeutics

Market Cap: CA$41.5m

Operates as a clinical-stage biotechnology company in Canada.

ZYUS Life Sciences

Market Cap: CA$39.9m

Manufactures and distributes cannabinoid-based therapeutics and product candidates for medical and adult recreational.

Microbix Biosystems

Market Cap: CA$39.0m

A life science company, develops and commercializes proprietary biological and technological solutions for human health and wellbeing in North America, Europe, and internationally.

Defence Therapeutics

Market Cap: CA$38.7m

Develops a biological drug enhancer platform that improves the efficacy and safety of a multitude of a multitude of biological/biosimilar-based pharmaceuticals used in the treatment of cancer and infectious diseases.

Thiogenesis Therapeutics

Market Cap: CA$38.5m

A clinical-stage biopharmaceutical company, develops thiol-based therapeutic compounds to treat unmet pediatric medical needs.

Medicenna Therapeutics

Market Cap: CA$38.3m

A clinical-stage immunotherapy company, engages in the development and commercialization of Superkines and empowered Superkines for the treatment of cancer, inflammation, and immune-mediated diseases.

Optimi Health

Market Cap: CA$38.0m

Operates as a pharmaceutical and nutraceutical drug manufacturing company in Canada.

Onco-Innovations

Market Cap: CA$37.6m

A pre-clinical stage biotechnology company, develops drug candidates for cancer treatments in Canada.

Voyageur Pharmaceuticals

Market Cap: CA$37.3m

Engages in acquiring, exploring, and developing raw materials for pharmaceutical products in the United States of America, the province of British Columbia, Canada, and the state of Utah.

Telescope Innovations

Market Cap: CA$36.0m

A chemical technology company, develops manufacturing processes and tools for the pharmaceutical and chemical industry in the United States and Canada.

iAnthus Capital Holdings

Market Cap: CA$34.9m

Owns and operates licensed cannabis cultivation, processing, and dispensary facilities in the United States.

Resverlogix

Market Cap: CA$34.4m

A late-stage clinical biotechnology company, develops therapeutics for patients with chronic illnesses.

Rubicon Organics

Market Cap: CA$33.1m

Engages in the production, processing, and sale of organic cannabis for the recreational and medical-use markets in Canada and internationally.

MediPharm Labs

Market Cap: CA$32.0m

Operates as a pharmaceutical company that produces and sells purified, pharmaceutical-like cannabis extracts, concentrates, active pharmaceutical ingredients, and advanced derivative products in Canada, Australia, Germany, and internationally.

More Life

Market Cap: CA$32.0m

A biotech company, focuses on advancing solutions to optimize human, animal, and plant health in Canada.

Devonian Health Group

Market Cap: CA$31.0m

Operates as a clinical stage biopharmaceutical corporation with novel therapeutic approaches targeting unmet medical needs in Canada and Internationally.

Quantum BioPharma

Market Cap: CA$30.7m

Operates as a biopharmaceutical company.

Neurothera Labs

Market Cap: CA$29.7m

Engages in the development of a portfolio of drugs based on cannabinoid molecules.

1CM

Market Cap: CA$28.8m

A multi-jurisdictional cannabis company, retails cannabis, alcohol, tobacco, nicotine, and consumer packaged goods in Canada.

Light AI

Market Cap: CA$28.2m

A healthcare technology company, focuses on the development of artificial intelligence and machine learning diagnostic digital healthcare solutions.

Sharp Therapeutics

Market Cap: CA$27.4m

A preclinical-stage drug discovery company, develops therapeutics for genetic diseases.

Pharmala Biotech Holdings

Market Cap: CA$23.5m

A biotechnology company, engages in the development, manufacture, and sale of MDMA and MDXX class molecules in service to the burgeoning clinical research community.

Lobe Sciences

Market Cap: CA$23.1m

A biopharmaceutical company, engages in the research and development of lipid technology to develop innovative treatments for orphan and rare diseases.

Ayr Wellness

Market Cap: CA$18.1m

Ayr Wellness Inc. cultivates, manufactures, and retails cannabis products and branded cannabis packaged goods in United States.

FLUENT

Market Cap: US$12.8m

Through its subsidiaries, cultivates, manufactures, processes, distributes, and sells medical cannabis products for medical and adult-use in the United States.

Avicanna

Market Cap: CA$17.5m

A commercial-stage biopharmaceutical company, engages in the research, development, advancement, and commercialization of evidence-based cannabinoid-based products and formulations for medical and pharmaceutical markets in Canada and internationally.

Hemostemix

Market Cap: CA$15.8m

A clinical stage biotechnology company, develops, manufactures, and commercializes blood-derived stem cell therapies for medical conditions in Canada.

Red White & Bloom Brands

Market Cap: CA$14.1m

Manufactures and distributes cannabis products and accessories in the United States, Canada, and internationally.

Rapid Dose Therapeutics

Market Cap: CA$13.6m

A life sciences company, provides drug delivery technologies in Canada.

Medicure

Market Cap: CA$13.6m

A biopharmaceutical company, engages in the research, development, and commercialization of human therapies in the United States.

Greenway Greenhouse Cannabis

Market Cap: CA$13.3m

Engages in the cultivation, processing, sale, bulk package, and wholesale of dry bud cannabis.

PharmaCielo

Market Cap: CA$12.7m

Together with its subsidiary, engages in cultivating, processing, and supplying medicinal-grade cannabis extracts in Canada.

Revive Therapeutics

Market Cap: CA$10.9m

A life sciences company, focuses on the research and development of therapeutics and diagnostics for infectious diseases, medical countermeasures, and rare disorders.

Noveris Health Sciences

Market Cap: CA$10.8m

A biotechnology company, engages in developing and commercializing solutions for treating mental health problems and enhancing vitality.